Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Weeks

Showing results (331-340 of 352) with videos related to

Pageof 36
Sort By:
Blood Advances|December 12, 2022
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemiaShai Shimony, Yiwen Liu, Yannis K Valtis, et al.
Journal of Clinical Medicine|February 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS SyndromeDavid B Beck, Maël Heiblig, Sinisa Savic, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Cardiovascular risk factors in myeloproliferative neoplasms: associations with survival and thrombotic outcomesJoan How, Orly Leiva, Robert Redd, et al.
The Cochrane Database of Systematic Reviews|November 24, 2020
Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysisWilliam R Parry Smith, Argyro Papadopoulou, Eleanor Thomas, et al.
Blood Advances|September 18, 2024
Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosisRathnam K Venkat, Robert A Redd, Amyah C Harris, et al.
Journal of the American College of Cardiology|May 17, 2023
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular DiseaseEsra D Gumuser, Art Schuermans, So Mi Jemma Cho, et al.
NEJM Evidence|July 24, 2023
Prediction of risk for myeloid malignancy in clonal hematopoiesisLachelle D Weeks, Abhishek Niroula, Donna Neuberg, et al.
Blood Advances|April 27, 2022
Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider supportAlfred Ian Lee, Leah E Masselink, Laura M De Castro, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 20, 2018
Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus studyS Meher, A Cuthbert, J J Kirkham, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2023
Association of Somatic TET2 Mutations With Giant Cell ArteritisMichelle L Robinette, Lachelle D Weeks, Ryan J Kramer, et al.
Pageof 36

Showing results (331-340 of 352) with videos related to

Sort By:
Pageof 36
Blood Advances|December 12, 2022
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemiaShai Shimony, Yiwen Liu, Yannis K Valtis, et al.
Journal of Clinical Medicine|February 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS SyndromeDavid B Beck, Maël Heiblig, Sinisa Savic, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Cardiovascular risk factors in myeloproliferative neoplasms: associations with survival and thrombotic outcomesJoan How, Orly Leiva, Robert Redd, et al.
The Cochrane Database of Systematic Reviews|November 24, 2020
Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysisWilliam R Parry Smith, Argyro Papadopoulou, Eleanor Thomas, et al.
Blood Advances|September 18, 2024
Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosisRathnam K Venkat, Robert A Redd, Amyah C Harris, et al.
Journal of the American College of Cardiology|May 17, 2023
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular DiseaseEsra D Gumuser, Art Schuermans, So Mi Jemma Cho, et al.
NEJM Evidence|July 24, 2023
Prediction of risk for myeloid malignancy in clonal hematopoiesisLachelle D Weeks, Abhishek Niroula, Donna Neuberg, et al.
Blood Advances|April 27, 2022
Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider supportAlfred Ian Lee, Leah E Masselink, Laura M De Castro, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 20, 2018
Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus studyS Meher, A Cuthbert, J J Kirkham, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 1, 2023
Association of Somatic TET2 Mutations With Giant Cell ArteritisMichelle L Robinette, Lachelle D Weeks, Ryan J Kramer, et al.
Pageof 36